Tail skin was removed from the tail bone and incubated overnight at 4°C in Hanks’ balanced salt solution (HBSS) (Gibco) and 0.25% trypsin (Gibco). The epidermis was then separated from the dermis and incubated on a rocking plate (100 rpm) at room temperature for 5 min. Basal cells were mechanically separated from the epidermis by flushing 10 times under the epidermis. Trypsin was then neutralized by adding Dulbecco’s modified Eagle’s medium. (DMEM) (Gibco) supplemented with 5% Chelex fetal calf serum (FCS) and filtrated on a 70-μm filter (Falcon). Cells were cultured in MEM supplemented with 10% FBS, hydrocortisone (0.4 μg/ml), epidermal growth factor (10 ng/ml), 2 × 10−9 MT3, 1% penicillin/streptomycin, 2 mM l-glutamine and incubated at 37°C with 20% O2 and 5% CO2. Twenty-four hours later, the cells were treated with recombinant vascular endothelial growth factor (VEGF) (50 ng/ml; R&D).

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.